Zahra Masoud

Zahra Masoud is a 5th year Pharmacology PhD candidate at the University of Minnesota-Twin Cities. Her research is focused on understanding the mechanisms underlying the initiation of breast cancer growth. After graduation, she will be working as a medical writer at Medpace, Inc located in Cincinnati, Ohio.

All articles by Zahra Masoud

Infectious Diseases

Updates and Challenges for WHO Antibiotic Targets

Zahra Masoud

September 9, 2020

Investigators reviewed patterns of antibiotic consumption in each of the WHO Access, Watch, and Reserve (AWaRe) categories over a span of 15 years and documented changes.

Practice Management

COVID-19: Seasonality of Coronaviruses May Provide Insight for Future SARS-CoV-2 Circulation

Zahra Masoud

August 24, 2020

Following the initial pandemic wave of SARS-CoV-2 infections, it is unclear what trajectory of transition SARS-CoV-2 might take.

Practice Management

Monitoring for Trends in COVID-19 Needed

Zahra Masoud

June 30, 2020

In response to the COVID-19 pandemic, New York State implemented a series of community mitigation strategies, and monitoring approaches are needed to assess the effect of these interventions.

Uncategorized

COVID-19: An Epidemiologic Review

Zahra Masoud

May 29, 2020

As uncertainty remains and data continues to be collected, the lack of effective drugs to treat coronavirus disease 2019 (COVID-19) suggest that the implementation of infection control interventions is needed.

Infections

Personalized Prophylaxis for Patients With ESBL Carriage Reduces Surgical Site Infection Risk

Zahra Masoud

May 21, 2020

Screening for extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-PE) carriage before and personalizing prophylaxis for carriers after elective colorectal surgery reduces the risk of surgical site infections.

Practice Management

Direct Challenge to Penicillin-Based Antibiotics Is Advantageous

Zahra Masoud

April 22, 2020

For people who have low-risk reaction histories in an inpatient setting, direct oral challenges may be a safe, effective, and less expensive option for penicillin allergy delabeling when compared to penicillin skin testing.

Infections

Acyclovir Not Beneficial With HSV Oropharyngeal Reactivation

Zahra Masoud

February 6, 2020

Preemptive use of acyclovir does not seem to reduce the duration of mechanical ventilation in critically ill patients with herpes simplex virus (HSV) oropharyngeal reactivation.